单克隆抗体作为切除黑色素瘤的辅助疗法
Islam Eljilany1, Julia R Garcia2, Basmala Jamal3
1Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Expert opinion on biological therapy
|March 24, 2025
概括
辅助单克隆抗体 (mAbs) 在高风险黑色素瘤患者中显著改善了无复发的生存率. 新的免疫疗法和向疗法也在研究,以改善结果和生活质量.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 黑色素瘤研究 黑色素瘤研究
背景情况:
- 系统辅助治疗对于高风险的切除黑色素瘤至关重要,以减少复发并改善生存率.
- 针对免疫检查点的单克隆抗体 (mAbs) 是辅助疗法的重大进展.
研究的目的:
- 在高风险黑色素瘤中审查辅助mAbs (抗CTLA-4,抗PD-1,抗LAG-3) 的临床试验.
- 讨论新的免疫疗法,向疗法,它们的优点和缺点,不良事件,生活质量影响和生物标志物数据.
主要方法:
- 关键临床试验的审查,涉及辅助单克隆抗体在切除高风险黑色素瘤.
- 对免疫检查点抑制剂 (ICI) 的数据分析,包括抗CTLA-4和抗PD-1疗法.
- 包括新出现的关于新辅助和辅助免疫疗法以及向疗法的数据.
主要成果:
- 免疫检查点抑制剂 (ICI) 在高风险黑色素瘤的辅助环境中显著改善无复发生存率 (RFS).
- 长期整体存活 (OS) 的好处在特定试验中证明了 ipilimumab.
- 新辅助性和辅助性ICI疗法显示,局部区域性晚期疾病的治疗结果有所改善.
结论:
- 辅助性ICI为高风险黑色素瘤患者提供显著的生存益处.
- 目前正在进行的研究探索新型免疫疗法和向药物,以进一步提高治疗疗效.
- 了解不良事件和生活质量影响对于优化辅助疗法选择至关重要.
更多相关视频
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
2.5K
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.0K
相关概念视频
01:27Tumor Immunotherapy
450
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
450
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:31Hybridoma Technology
13.9K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.9K